|
gptkbp:instanceOf
|
gptkb:drug
peptide
|
|
gptkbp:administeredBy
|
injection
|
|
gptkbp:alternativeName
|
Parathyroid hormone 1-34
Teriparatide
|
|
gptkbp:approvalYear
|
2002
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
H05AA02
|
|
gptkbp:CASNumber
|
52232-67-4
|
|
gptkbp:chemicalFormula
|
C181H291N55O51S2
|
|
gptkbp:contraindication
|
gptkb:hypercalcemia
gptkb:Paget's_disease
bone metastases
prior radiation therapy to the skeleton
unexplained elevations of alkaline phosphatase
|
|
gptkbp:derivedFrom
|
gptkb:parathyroid_hormone
|
|
gptkbp:discoveredBy
|
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:halfLife
|
about 1 hour
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
PTH 34
|
|
gptkbp:indication
|
glucocorticoid-induced osteoporosis
postmenopausal osteoporosis
osteoporosis in men
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:length
|
34 amino acids
|
|
gptkbp:marketedAs
|
Forteo
|
|
gptkbp:mechanismOfAction
|
stimulates bone formation
|
|
gptkbp:routeOfAdministration
|
subcutaneous injection
|
|
gptkbp:sideEffect
|
gptkb:hypercalcemia
nausea
leg cramps
|
|
gptkbp:UNII
|
GDU7A39867
|
|
gptkbp:usedFor
|
gptkb:bone
|
|
gptkbp:bfsParent
|
gptkb:Manitoba_Highway_System
gptkb:PTH_3
gptkb:Manitoba_provincial_highway_system
|
|
gptkbp:bfsLayer
|
7
|